Search

2024 JUL 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Nervous System Diseases and Conditions - Central [...]

Byline: Our Bureau Medica, the fastest growing healthcare group in Eastern India is geared to set up a world class cancer treatment facility at Kolkata, as a responsible service provider, [...]

Byline: Philip J. DiSaia, Elizabeth A. Grosen, Tom Kurosaki, Maureen Gildea, Beth Cowan, Hoda Anton-Culver Keywords: Breast cancer; hormone replacement therapy Abstract: OBJECTIVE: Our purpose was to measure any adverse effect (if one exists) of hormone replacement therapy administered to breast cancer survivors. STUDY DESIGN: Forty-one patients from a group of 77 patients who received hormone replacement therapy after therapy for breast cancer were matched with 82 comparison patients not receiving hormone replacement therapy. Both groups were taken from the same population on the basis of cancer registry of the Cancer Surveillance Program of Orange County and were compared with regard to survival results. RESULTS: An analysis of survival time and disease-free time revealed no statistically significant difference between the two groups. CONCLUSIONS: No obvious adverse effect of hormone replacement therapy could be shown in this pilot study. A case is made for a prospective randomized trial. (AM J OBSTET GYNECOL 1996;174:1494-8.) Author Affiliation: Irvine, California Article History: Received 24 July 1995; Revised 15 September 1995; Accepted 26 October 1995 Article Note: (footnote) [star] From the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology,a and the Epidemiology Division, Department of Medicine,b University of California, Irvine. , [star][star] Reprint requests: Philip J. DiSaia, MD, Department of Obstetrics and Gynecology, University of California, Irvine Medical Center, 101 The City Drive, South, Orange, CA 92668., a 0002-9378/96 $5.00 + 0 6/1/70204

In May 1985, I lay in a room without sunlight hearing machines without souls hissing and bellowing. My surgeon sat down at my bedside. 'We didn't find fibroids,' Dr. Jonas [...]

AFTER I WAS DIAGNOSED with inflammatory breast cancer at 31, I spent a lot of time with my doctor, discussing my ongoing care. The unspoken (and sometimes spoken) words hung [...]

Estrogen Replacement Therapy for Ovarian Cancer Survivors Abstract & Commentary Synopsis: Postoperative estrogen replacement therapy did not have a negative influence on the disease-free survival and overall survival of ovarian [...]

Use of vitamin and mineral supplements is prevalent among cancer survivors, in spite of the lack of conclusive evidence that taking these supplements is helpful, according to a comprehensive review [...]

Preventable Risk Factors Pose Serious Threat to Heart Health of Childhood Cancer Survivors: For childhood cancer survivors, risk factors associated with lifestyle, particularly hypertension, dramatically increase the likelihood of developing [...]

A substantial number of survivors of childhood cancer have a marked disease burden that doesn't emerge until their young adult and mid-adult years, according to a Dutch study. In the [...]

HOUSTON -- Cancer survivors often have fatigue, memory problems, and other side effects for many months after treatment, Pascal Jean-Pierre, Ph.D., reported at the annual meeting of the American Society [...]

ORLANDO, FLA. -- Primary care physicians and other clinicians from specialties outside of oncology can expect to find their respective roles spelled out in new guidelines under development for medical [...]